Highlights
NASDAQ: RGNX       Regenxbio Inc
Last Price Today's Change   Day's Range   Trading Volume
36.735   +0.135 (0.37%)  36.00 - 37.31  110,023

Overview

 
Avg Volume (4 weeks):522,170
4 Weeks Range:34.02 - 41.66
4 Weeks Price Volatility (%):
35.54%
52 Weeks Range:30.38 - 65.62
52 Weeks Price Volatility (%):
18.03%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

  Be the first to like this.
 


 

2966  2563  429  3019 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.909+0.099 
 CHK 0.697-0.005 
 AMD 38.25+0.73 
 CSCO 44.665-3.795 
 AABA 19.630.00 
 CPE 4.305-0.155 
 SNNA 0.305+0.145 
 NIO 1.734-0.166 
 NOK 3.35-0.12 
 AMRN 21.490.00 
Partners & Brokers